Prof. Dava Newman speaks with Esther Paniagua of El País about her goals for her new role as director of the MIT Media Lab. “We want to accelerate positive change for people,” says Newman in this interview, which is in Spanish. “Trying to answer the big questions: equity, justice, inequality, climate and sustainability, people and communication, and education and learning.”
Bloomberg Businessweek reporter Peter Coy spotlights how the loss of several people close to Prof. Andrew Lo inspired him to explore how the field of finance could help advance treatments for orphan diseases. “Finance plays a huge role, sometimes way too big a role, in how drugs get developed,” says Lo. Fixing the financing model, could have a “tremendous, tremendous impact on health care.”
In an opinion piece for The Los Angeles Times, Institute Professor Phillip Sharp, Ellen Sigal of the Friends of Cancer Research and Sherry Lansing of the Sherry Lansing Foundation underscore the importance of selecting an effective leader for the FDA. “In order to restore trust in the FDA, and restore morale within, a permanent leader with expansive experience, medical expertise and the confidence of agency staff and the American public needs to be nominated in short order,” they write.
Writing for STAT, Prof. Emeritus Jeffrey Harris explores how community health centers “can play a crucial role in reducing the burden of the Covid-19 epidemic in the difficult winter months to come. They can serve as critical safety valves at a time when acute care hospitals and emergency rooms are saturated with patients.”
Prof. Earl Miller speaks with Edgar Herwick III of GBH Radio about multitasking. "You can only think of a very small bit of information, one train of thought at a time," explains Miller. "So when you think you’re multitasking, what you’re actually doing is task switching. You’re switching back and forth. The result is you have decreased productivity, increased mistakes, and a decrease of quality of thought.”
Writing for the New York Daily News, Prof. Sandy Alexandre underscores the importance of having a role for the humanities in the White House. “Ultimately, presidents who are vocal about believing in science — the power of facts — should also be vocal about their belief in and support of the humanities — the power of history, language, the imagination, critical thinking and hope,” writes Alexandre.
Forbes contributor Wayne Rush spotlights Prof. David Rand’s research examining how to most effectively combat the spread of misinformation. “They forget to think about whether it’s true, but rather how many likes they’ll get,” says Rand of why people share misinformation on social media. “Another feature of social media is that people are more likely to be friends with people who share common ideas.”
Prof. Daron Acemoglu speaks with Greg Rosalsky of NPR’s Planet Money about his book, “Why Nations Fail,” whether the attack on the U.S. Capitol signals difficulties for U.S. institutions, and how politicians can create more shared prosperity through a “good jobs” agenda. "We are still at a point where we can reverse things," Acemoglu says. "But I think if we paper over these issues, we will most likely see a huge deterioration in institutions. And it can happen very rapidly."
Bloomberg reporters Benjamin Bain, Jennifer Epstein and Robert Schmidt spotlight the work Prof. Gary Gensler, who has been nominated as the next chair of the Securities and Exchange Commission. Gensler “not only knows how to mobilize a bureaucratic federal agency but also understands the often impenetrable ways that Wall Street makes money -- and how firms use that complexity to turn regulation in their favor.”
President-elect Joe Biden has selected Prof. Gary Gensler to serve as the next chair of the Securities and Exchange Commission, reports Marcy Gordon and Zeke Miller for the AP. Gensler “was an assistant Treasury secretary in the Clinton administration and later headed the CFTC during Barack Obama’s term. With a background of having worked for nearly 20 years at Wall Street powerhouse Goldman Sachs, Gensler surprised many by being a tough regulator of big banks as CFTC chairman.”
NBC News reporter Martha White writes that Prof. Gary Gensler has been selected as President-elect Joe Biden’s nominee to lead the Securities and Exchange Commission. “Gensler is a terrific choice to head the agency," said Barbara Roper, director of investor protection at the Consumer Federation of America. "He’s as knowledgeable about the markets as anyone on Wall Street, so he can’t be intimidated. He’s a seasoned regulator who knows how to get things done.”
Prof. Gary Gensler will be the Biden administration’s pick to lead the Securities and Exchange Commission, reports Matthew Goldstein, Lauren Hirsch and Andrew Ross Sorkin for The New York Times. “Mr. Gensler is a veteran regulator who played a central role in bringing the big banks to heel in the aftermath of the 2008 financial crisis, giving new teeth to a watchdog agency.”
CBS News spotlights how two MIT researchers have been named to key roles on the Biden administration’s science team. Prof. Eric Lander, president and founding director of the Broad Institute, has been nominated to lead the Office of Science and Technology Policy, and Maria Zuber, MIT’s vice president for research, will co-chair the President's Council of Advisors on Science and Technology. Zuber said she hopes to "restore trust in science, and pursue breakthroughs that benefit all people."
Prof. Eric Lander, president and founding director of the Broad Institute, and Maria Zuber, MIT’s vice president for research, have been nominated to leading roles on the Biden administration's science team, report Nidhi Subbaraman and Alexandra Witze for Nature. “These are excellent appointments, highly qualified and experienced, and well grounded in science,” says Rita Colwell, a professor at University of Maryland at College Park and former director of the National Science Foundation
AP reporter Seth Borenstein writes about how President-elect Joe Biden is nominating Prof. Eric Lander of the Broad Institute to serve as his chief science officer and lead the Office of Science and Technology Policy, and has selected Maria Zuber, vice president for research at MIT, to co-chair the President’s Council of Advisors on Science and Technology. Francis Collins, director of the NIH, called Lander, “brilliant, visionary, exceptionally creative and highly effective in aspiring others. I predict he will have a profound transformational effect on American science.”